These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 8387803

  • 1. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
    Suto Y, Kato T, Matsuo T, Kamba M, Shimatani Y, Ohuchi Y, Nakamura K, Ohta Y.
    Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
    Hussain MZ, Ohtomo K, Kachi K, Uchiyama G, Itai Y.
    Radiat Med; 1994 May; 12(1):1-5. PubMed ID: 8016397
    [Abstract] [Full Text] [Related]

  • 4. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
    Kamba M, Suto Y, Kato T.
    Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
    Suto Y, Ametani M, Kamba M, Sugihara S.
    Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
    [Abstract] [Full Text] [Related]

  • 7. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K.
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [Abstract] [Full Text] [Related]

  • 8. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma.
    Sugihara S, Suto Y, Yoshida K.
    Br J Radiol; 1997 Aug; 70(836):791-7. PubMed ID: 9486042
    [Abstract] [Full Text] [Related]

  • 9. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X, Xu YK, Huang QL, Wu YK.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ, Kim MJ, Kim KW.
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MR imaging of hepatocellular carcinoma.
    Onaya H, Itai Y.
    Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):757-68. PubMed ID: 11149678
    [Abstract] [Full Text] [Related]

  • 14. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
    Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, Gabata T, Takashima T, Nakanuma Y, Terada T, Ida M.
    Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS, Jaw TS, Liu GC, Wang YM, Chen SH, Kuo YT, Jao JC, Li CW, Tsai KB.
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma exhibiting a concentric structure of different histologic grades: evaluation by chondroitin sulfate iron colloid-enhanced MR imaging.
    Kamba M, Suto Y, Kodama F, Ohta Y, Kobayashi J, Horie Y, Kawasaki H.
    J Magn Reson Imaging; 1996 Oct; 6(2):406-8. PubMed ID: 8859586
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of iron colloid-enhanced MRI in differentiating experimental hepatocellular carcinoma from hyperplastic nodules in rats: analysis by microautoradiography.
    Suto Y, Kodama F.
    Br J Radiol; 1996 Dec; 69(828):1139-44. PubMed ID: 9135470
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chondroitin sulfate iron colloid as an MR contrast agent for the hepatic reticuloendothelial system.
    Kato T, Suto Y, Matsuo T.
    J Comput Assist Tomogr; 1993 Dec; 17(4):603-8. PubMed ID: 8392526
    [Abstract] [Full Text] [Related]

  • 20. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma.
    Ebara M, Fukuda H, Kojima Y, Morimoto N, Yoshikawa M, Sugiura N, Satoh T, Kondo F, Yukawa M, Matsumoto T, Saisho H.
    Radiology; 1999 Jan; 210(1):81-8. PubMed ID: 9885591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.